Wall Street is getting excited about these Chinese stocks
Investment analysts have upgraded at least three U.S.-listed Chinese stocks to buy so far this month. The positive view comes as the many Chinese companies are reporting earnings for the…
Wariness over rate cuts lingers
Traders react as Federal Reserve Chair Jerome Powell is seen delivering remarks on a screen, on the floor of the New York Stock Exchange (NYSE) in New York City, March…
Is progress on inflation stalling?
Prices on displayed in a New York grocery store on Feb. 1, 2023. Leonardo Munoz | Corbis News | Getty Images This report is from today’s CNBC Daily Open, our…
Big Tech earnings loom large
A slogan related to Artificial Intelligence (AI) is displayed on a screen in Intel pavilion, during the 54th annual meeting of the World Economic Forum in Davos, Switzerland, January 16,…
Analysts love these biotech stocks, giving 4 more than 100% upside
The health-care sector may have done poorly in the last couple of years, but analysts are bullish on it right now . “Just two weeks into 2024, the healthcare sector…
Citi and others are bullish on biotech, medtech and more
2023 wasn’t a good year for the health-care sector, but some investors expect it to make a comeback this year — highlighting biotech and medical tech as areas to watch.…
Citi updated its ‘highest conviction’ stock list for Europe
Citi just refreshed its highest conviction stock ideas for Europe. The list comprises its analysts’ strongest buy and sell ideas for the next 12 months, according to Citi. It says…
‘Top conviction call:’ Analysts say time to buy oil, energy stocks
Energy stocks been laggards for much of this year, and were the only sector not to rise in the hot November rally — but some analysts are still bullish. In…
Citi is so bullish on this biotech stock it gave it an 800% upside
Citi is so bullish on one biotech firm that it has given its shares a target price that represents around 800% upside. That company is U.S.-listed Biomea Fusion , which…
Here’s what Wall Street is saying about Wegovy following Novo Nordisk’s key study
Analysts are largely optimistic about a new class of anti-obesity medications following a landmark study released over the weekend. Novo Nordisk ‘s Select study of about 17,500 people found the…